Endothelial function and insulin sensitivity during acute non-esterified fatty acid elevation: Effects of fat composition and gender
dc.citation.issue | 6 | |
dc.citation.volume | 25 | |
dc.contributor.author | Newens KJ | |
dc.contributor.author | Thompson AK | |
dc.contributor.author | Jackson KG | |
dc.contributor.author | Williams CM | |
dc.coverage.spatial | Netherlands | |
dc.date.available | 2015-06 | |
dc.date.available | 2015-03-05 | |
dc.date.issued | 14/03/2015 | |
dc.description.abstract | Background and aims We have reported that adverse effects on flow-mediated dilation of an acute elevation of non-esterified fatty acids rich in saturated fat (SFA) are reversed following addition of long-chain (LC) n-3 polyunsaturated fatty acids (PUFA), and hypothesised that these effects may be mediated through alterations in insulin signalling pathways. In a subgroup, we explored the effects of raised NEFA enriched with SFA, with or without LC n-3 PUFA, on whole body insulin sensitivity (SI) and responsiveness of the endothelium to insulin infusion. Methods and results Thirty adults (mean age 27.8 y, BMI 23.2 kg/m2) consumed oral fat loads on separate occasions with continuous heparin infusion to elevate NEFA between 60 and 390 min. For the final 150 min, a hyperinsulinaemic-euglycaemic clamp was performed, whilst FMD and circulating markers of endothelial function were measured at baseline, pre-clamp (240 min) and post-clamp (390 min). NEFA elevation during the SFA-rich drinks was associated with impaired FMD (P = 0.027) whilst SFA + LC n-3 PUFA improved FMD at 240 min (P = 0.003). In males, insulin infusion attenuated the increase in FMD with SFA + LC n-3 PUFA (P = 0.049), with SI 10% greater with SFA + LC n-3 PUFA than SFA (P = 0.041). Conclusion This study provides evidence that NEFA composition during acute elevation influences both FMD and SI, with some indication of a difference by gender. However our findings are not consistent with the hypothesis that the effects of fatty acids on endothelial function and SI operate through a common pathway. This trial was registered at clinical trials.gov as NCT01351324 on 6th May 2011. | |
dc.description.publication-status | Published | |
dc.format.extent | 575 - 581 | |
dc.identifier | https://www.ncbi.nlm.nih.gov/pubmed/25921849 | |
dc.identifier | S0939-4753(15)00060-5 | |
dc.identifier.citation | Nutr Metab Cardiovasc Dis, 2015, 25 (6), pp. 575 - 581 | |
dc.identifier.doi | 10.1016/j.numecd.2015.03.004 | |
dc.identifier.eissn | 1590-3729 | |
dc.identifier.elements-id | 239495 | |
dc.identifier.harvested | Massey_Dark | |
dc.identifier.uri | https://hdl.handle.net/10179/13225 | |
dc.language | eng | |
dc.publisher | Elsevier | |
dc.relation.isPartOf | Nutr Metab Cardiovasc Dis | |
dc.subject | Fatty acids | |
dc.subject | Flow-mediated dilatation | |
dc.subject | Hyperinsulinaemic-euglycaemic clamp | |
dc.subject | Insulin signalling | |
dc.subject | Nitric oxide | |
dc.subject | Adult | |
dc.subject | Biomarkers | |
dc.subject | Blood Glucose | |
dc.subject | Brachial Artery | |
dc.subject | Cross-Over Studies | |
dc.subject | Endothelium, Vascular | |
dc.subject | England | |
dc.subject | Fatty Acids, Nonesterified | |
dc.subject | Fatty Acids, Omega-3 | |
dc.subject | Female | |
dc.subject | Glucose Clamp Technique | |
dc.subject | Humans | |
dc.subject | Insulin | |
dc.subject | Insulin Resistance | |
dc.subject | Male | |
dc.subject | Single-Blind Method | |
dc.subject | Time Factors | |
dc.subject | Ultrasonography | |
dc.subject | Up-Regulation | |
dc.subject | Vasodilation | |
dc.subject.anzsrc | 11 Medical and Health Sciences | |
dc.title | Endothelial function and insulin sensitivity during acute non-esterified fatty acid elevation: Effects of fat composition and gender | |
dc.type | Journal article | |
pubs.notes | Not known | |
pubs.organisational-group | /Massey University | |
pubs.organisational-group | /Massey University/College of Sciences |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 1-s2.0-S0939475315000605-main.pdf
- Size:
- 491.76 KB
- Format:
- Adobe Portable Document Format
- Description: